Nautilus Biotechnology, Inc. Made Big Gain
Mon, Nov 03, 2025 at 07:08 PM
Nautilus Biotechnology, Inc. (NAUT:NASDAQ) shot up at $1.85, representing a gain of 39.1%. On Mon, Nov 03, 2025, NAUT:NASDAQ touched a New 2-Week High of $1.85. The stock appeared on our News Catalysts scanner on Mon, Nov 03, 2025 at 09:46 AM in the 'BIOTECH' category. From Mon, Oct 20, 2025, the stock recorded 50.00% Up Days and 63.64% Green Days
About Nautilus Biotechnology, Inc. (NAUT:NASDAQ)
Nautilus Biotechnology Inc is a development stage life sciences company creating a platform technology for quantifying and unlocking the complexity of the human proteome.
Top 10 Gainers:
- Prelude Therapeutics Incorporated (PRLD:NASDAQ), 150.31%
- Resolute Holdings Management (RHLD:NYSE), 96.81%
- Resolute Holdings Management, Inc. (RHLD:NASDAQ), 96.81%
- Hempacco Co., Inc. (HPCO:NASDAQ), 80%
- Terns Pharmaceuticals, Inc. (TERN:NASDAQ), 69.85%
- Davis Commodities Limited (DTCK:NASDAQ), 66.84%
- Kuke Music Holding Limited (KUKE:NYSE), 39.18%
- Nautilus Biotechnology, Inc. (NAUT:NASDAQ), 39.1%
- Raytech Holding Limited (RAY:NASDAQ), 31.94%
- EZGO Technologies Ltd. (EZGO:NASDAQ), 29.11%